PET/CT Can Help Detect Recurrent Thyroid Disease
Using PET/CT imaging can help clinicians detect recurrent thyroid disease among patients who have negative radioiodine scans.
PET/CT can accurately detect recurrent thyroid disease not demonstrated by radioiodine scans, according to a presentation that will be given in September at the Royal College of Radiologists Annual Scientific Meeting, which will be held in London, UK.
Researchers sought to determine the usefulness of PET/CT in detecting recurrent thyroid disease in patients who had a negative thyroid scan, but raised serum thyroglobulin levels. They performed a three-year retrospective study that involved 23 patients (average age, 54.2) who had thyroid cancer. All patients had a negative radioiodine scan and raised serum thyroglobulin levels.
All patients (11 males, 12 females) underwent PET/CT examination. The researchers found that for 12 patients (52.2 percent), the PET/CT detected recurrent thyroid lesions or distant metastases that had not been seen on radioiodine studies. There was also a statistically significant difference in the serum thyroglobulin levels between patients who were found to have positive lesions and those who did not have lesions.
The researchers concluded that the PET/CT imaging could accurately detect recurrent thyroid disease that was not found with radioiodine scans.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
